Overview

Vaped Marijuana to Attenuate Naloxone-Precipitated Withdrawal

Status:
Not yet recruiting
Trial end date:
2023-12-30
Target enrollment:
Participant gender:
Summary
The goal of the proposed, proof-of-concept study is to test the combined effects of vaporized marijuana [Delta-9-tetrahydracannabinol (THC)] with NLX as a proof of concept towards the possible development of a combined overdose reversal agent with improved tolerability.
Phase:
Phase 2
Details
Lead Sponsor:
New York State Psychiatric Institute
Treatments:
Naloxone